Pictet Asset Management (Switzerland)’s Ultragenyx Pharmaceutical RARE Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio RARE Stock Details RARE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$26.9M	Buy
2023 Q1	$13.4M	Buy
2022 Q4	$3.73M	Buy
2022 Q3	$2.42M	Buy
2022 Q2	$263K	Hold
2022 Q1	$320K	Hold
2021 Q4	$370K	Hold
2021 Q3	$397K	Buy